Effector immune mechanisms in cancer.
D000911:Antibodies, Monoclonal / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular; D007113:Immunity, Innate; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000032:analysis / Q000276:immunology* / Q000502:physiology; D007951:Leukemia, Myeloid / Q000276:immunology; D008264:Macrophages / Q000502:physiology*; D009369:Neoplasms / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000502:physiology; D014410:Tumor Stem Cell Assay
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D007376:Interleukin-2; D003165:Complement System Proteins